Chuan Shen

Chuan Shen is a Principal Scientist at Pyxis Oncology since April 2022. Prior to that, they worked as a Scientist II at Takeda from January 2019 to April 2022. From March 2013 to April 2019, they held the position of Senior Scientist at Shire Pharmaceuticals. Before that, they worked as a Postdoctoral Research Fellow at Dana-Farber Cancer Institute in Dr. William Kaelin Lab from August 2006 to March 2013. In addition, they were a Graduate Research Assistant at Iowa State University in Dr. Jo Anne Powell-Coffman Lab from August 2000 to July 2006, where they studied the function and regulation of hypoxia-signaling pathway in the genetic model system C. elegans.

Chuan Shen earned a Doctor of Philosophy (Ph.D.) in Toxicology & Genetics from Iowa State University between 2000 and 2006.